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Abstract
Coxiella burnetii is an obligate intracellular bacterial pathogen and a causative agent of cul-
ture-negative endocarditis. While C. burnetii initially infects alveolar macrophages, it has
also been found in lipid droplet (LD)-containing foamy macrophages in the cardiac valves of
endocarditis patients. In addition, transcriptional studies of C. burnetii-infected macro-
phages reported differential regulation of the LD coat protein-encoding gene perilipin 2 (plin-
2). To further investigate the relationship between LDs and C. burnetii, we compared LD
numbers using fluorescence microscopy in mock-infected and C. burnetii-infected alveolar
macrophages. On average, C. burnetii-infected macrophages contained twice as many LDs
as mock-infected macrophages. LD numbers increased as early as 24 hours post-infection,
an effect reversed by blocking C. burnetii protein synthesis. The observed LD accumulation
was dependent on the C. burnetii Type 4B Secretion System (T4BSS), a major virulence
factor that manipulates host cellular processes by secreting bacterial effector proteins into
the host cell cytoplasm. To determine the importance of LDs during C. burnetii infection, we
manipulated LD homeostasis and assessed C. burnetii intracellular growth. Surprisingly,
blocking LD formation with the pharmacological inhibitors triacsin C or T863, or knocking out
acyl-CoA transferase-1 (acat-1) in alveolar macrophages, increased C. burnetii growth at
least 2-fold. Conversely, preventing LD lipolysis by inhibiting adipose triglyceride lipase
(ATGL) with atglistatin almost completely blocked bacterial growth, suggesting LD break-
down is essential for C. burnetii. Together these data suggest that maintenance of LD
homeostasis, possibly via the C. burnetii T4BSS, is critical for bacterial growth.
Introduction
Lipid droplets (LDs) are dynamic cytoplasmic organelles which store cellular lipids in eukary-
otic cells. LDs are uniquely comprised of a phospholipid monolayer surrounding a hydrophobic
core of neutral lipids, primarily sterol esters and triacylglycerols (TAGs). LD assembly begins
with neutral lipid synthesis, where fatty acyl CoA synthetases generate long chain fatty acids
which are converted to sterol esters and triacyglycerols by acyl-CoA:cholesterol acyltransferase
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(ACAT) and acyl-CoA:diacylglycerol acyltransferase (DGAT), respectively. Progressive accu-
mulation of neutral lipids in the ER leads to budding of the lipid ester globule surrounded by
the ER membrane cytoplasmic leaflet, thus forming LDs [1, 2]. Inversely, adipose triglyceride
lipase (ATGL) [3] and hormone sensitive lipase (HSL) [4] mediate LD breakdown and release
of free cholesterol and fatty acids. Functionally, LDs serve as intracellular lipid reservoirs for
membrane synthesis or energy metabolism. In addition, LDs are linked to a range of cellular
functions including protein storage, protein degradation and signaling [2, 5].
LDs are emerging as important players during host-pathogen interactions. During infection
of host cells, Hepatitis C virus (HCV) [6] and Dengue virus [7] co-opt LDs as platforms for viral
assembly and replication. Even though blocking LD formation attenuates HCV and Dengue
virus replication in vitro, the importance of LDs during viral infection still remains elusive [8].
LD numbers increased in host cells during infection with several pathogens including HCV [6]
and Dengue virus [7], as well as the protozoan parasites Trypanosoma cruzi [9], Plasmodium
berghei [10], Toxoplasma gondii [11], Leishmania amazonensis [12] and Leishmania major [13].
In addition, infection with the intracellular bacterial pathogens Chlamydia spp. [14], Mycobacte-
rium spp. [15–18], Orientia tsutugamushi [19], and Salmonella typhimurium [20] also led to
increased LD numbers. Since fatty acids released from host TAGs and sterols can serve as car-
bon sources during infection [21], C. trachomatis [14, 22] and M. tuberculosis [15] are proposed
to use LD components as a major source of energy and nutrients. Furthermore, in cells infected
with M. leprae [23], M. bovis [16], T. cruzi [24], and Leishmania infantum chagasi [25], LDs
serve as a source of prostaglandin and leukotriene eicosanoids, important signaling lipids which
modulate inflammation and the immune response. These LD-derived eicosanoids potentially
favor intracellular pathogen survival by downregulating the immune response [26].
LDs have been implicated during infection by Coxiella burnetii, a gram-negative intracellu-
lar bacterium and the causative agent of human Q fever. Primarily spread through aerosols, C.
burnetii acute infection is characterized by a debilitating flu-like illness, while chronic disease
results in endocarditis. Although in vitro and in vivo C. burnetii can infect a wide range of cells
including epithelial cells and fibroblasts, the bacterium first infects alveolar macrophages dur-
ing natural infection. Inside the host cell, C. burnetii directs formation of a specialized lyso-
some-like compartment called the parasitophorous vacuole (PV) which is essential for C.
burnetii survival. PV biogenesis requires the C. burnetii type 4B secretion system (T4BSS),
which secretes effector proteins into the host cell cytoplasm where they manipulate a wide
range of cellular processes. While not established to be T4BSS-dependent, C. burnetii is
thought to manipulate LDs and other components of host cell lipid metabolism [27–30]. C.
burnetii-containing LD-filled foam cells were found in heart valves of an infected patient [31],
and LDs were observed in the C. burnetii PV lumen of infected human alveolar macrophages
[32]. Further, two separate microarray analyses reported differential regulation of the LD coat
protein plin-2 in C. burnetii-infected human macrophage-like cells (THP-1) [29, 30], suggest-
ing C. burnetii induced changes in host cell LDs. Intriguingly, siRNA depletion of the phos-
pholipase involved in LD breakdown, PNPLA2 (also known as ATGL), increased the number
of C. burnetii PVs in HeLa epithelial cells [33]. In addition, treatment of monkey kidney epi-
thelial cells (Vero cells) with a broad spectrum antiviral molecule ST699 which localizes to
host cell LDs inhibited C. burnetii intracellular growth [34]. Despite these observations, the
importance of LDs during C. burnetii infection is not known. In this study, we further exam-
ined the relationship between host LDs and C. burnetii. We observed a T4BSS-dependent
increase in LD numbers in infected mouse alveolar and human monocyte-derived macro-
phage cell lines. Furthermore, manipulation of LD homeostasis significantly altered C. burnetii
intracellular growth, thus strongly indicating that LDs play an important role during C. burne-
tii infection.
Lipid droplets during Coxiella burnetii infection
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Materials and methods
Bacteria and mammalian cells
C. burnetii Nine Mile Phase II (NMII; clone 4, RSA439) were purified from Vero cells (African
green monkey kidney epithelial cells, ATCC CCL-81; American Type Culture Collection,
Manassas, VA) and stored as previously described [35]. For experiments examining T4BSS-
dependent accumulation of LDs, NMII and the dotA mutant [36] were grown for 4 days in
ACCM-2, washed twice with phosphate buffered saline (PBS) and stored as previously
described [37]. Vero, mouse alveolar macrophages (MH-S; ATCC CRL-2019) and human
monocytes (THP-1; ATCC TIB-202) were maintained in RPMI (Roswell Park Memorial Insti-
tute) 1640 medium (Corning, New York, NY, USA) containing 10% fetal bovine serum
(Atlanta Biologicals, Norcross, GA, USA) at 37˚C and 5% CO2 and human embryonic kidney
293 (HEK293T; ATCC CRL-3216) in DMEM (Dulbecco’s Modified Eagle Medium) (Corning,
New York, NY, USA) containing 10% fetal bovine serum at 37˚C and 5% CO2. THP-1 cells
were differentiated with 200 nM of phorbol 12-myristate 13-acetate (PMA) for 24 hours. PMA
was removed, and the cells rested for 48 hours prior to infection. The multiplicity of infection
(MOI) was optimized at 37˚C and 5% CO2 for each bacterial stock, cell type and infection con-
dition for a final infection of ~1 internalized bacterium/cell.
Generating acat-1-/- MH-S cell line
The guide RNA sequence 50TCGCGTCTCCATGGCTGCCC30 to mouse acat-1 was selected
using the optimized CRISPR design site crispr.mit.edu. Oligonucleotides were synthesized
(IDT, Coralville, IA, USA), annealed, and cloned into the lentiCRISPRv2 plasmid (a gift from
Feng Zhang, Addgene # 52961, Cambridge, MA, USA) [38], at the BsmBI restriction site to
generate plentiCRISPRv2-acat-1. To generate lentivirus, HEK293T cells were co-transfected
with plentiCRISPRv2-acat-1 and packaging plasmids pVSVg (Addgene # 8454), pRSV-Rev
(Addgene # 12253), and pMDLg/pRRE (Addgene # 12251) using FuGENE6 reagent (Promega,
Madison, WI, USA). At 48 hours post-transfection, supernatant was collected, centrifuged at
3000xg, and then filtered with 0.45µm filter to remove cells and debris. Supernatant was con-
centrated using the Lenti-X concentrator (Catalog # PT4421-2, Clontech, USA) and viral RNA
isolated using Viral RNA isolation kit (Catalog # 740956, Macherey-Nagel, Germany) to deter-
mine viral titer using Lenti-X qRT-PCR titration kit (Catalog # PT4006-2, Clontech). Viral
titers were optimized for transduction of MH-S cells to generate stable acat-1-/- cells.
2x105 MH-S cells were plated in a 6 well plate and transduced with 5.8 x 106 viral particles/
ml. 1 µg/ml puromycin was used for selection 48 hours post-transduction and continued for
24 hours. The puromycin was then removed and the cells allowed to recover before isolating
individual clones by limiting dilution.
To confirm disruption of acat-1, clones were lysed in 2% SDS (Sigma-Aldrich, St. Louis,
MO, USA) for SDS-PAGE and immunoblotting with 1:1000 rabbit anti-mouse ACAT1-speci-
fic antibody (Catalog # NBP189285, Novus Biologicals, Littleton, CO, USA) and 1:4000
GAPDH loading control monoclonal antibody (Catalog # MA5-15738, ThermoFisher Scien-
tific, Waltham, MA, USA).
Gene expression analysis of LD genes
2x105 MH-S cells were infected in a 6 well plate. At day 1 post-infection, host cell RNA was iso-
lated using RNEasy mini kit (Catalog # 74104, Qiagen) and reverse transcribed to cDNA using
Superscript first strand synthesis system (Catalog # 11904–018, Invitrogen). Gene expression
analysis was performed using TaqMan array mouse lipid regulated genes (Catalog # 4415461,
Lipid droplets during Coxiella burnetii infection
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Applied Biosystems). Fold change was calculated compared to mock-infected cells in 6 inde-
pendent experiments.
LD quantitation
1x105 MH-S cells were plated onto ibidi-treated channel µslide VI0.4 (3x103 cells per channel;
Ibidi, Verona, WI) and allowed to adhere overnight. After infecting with C. burnetii for 1
hour, cells were gently washed with phosphate buffered saline (PBS) to remove extracellular
bacteria, and incubated in 10% FBS-RPMI. For blocking bacterial protein synthesis, infected
cells were incubated with 3 µg/ml chloramphenicol containing 10% FBS-RPMI for the remain-
der of experiment, replenishing media every 24 hours. At different times post-infection,
infected cells were fixed with 2.5% paraformaldehyde on ice for 15 min, then permeabilized/
blocked for 15 min with 0.1% saponin and 1% bovine serum albumin (BSA) in PBS (saponin-
BSA-PBS) and stained with 1:1000 rabbit anti-mouse PLIN2 primary antibody (Catalog #
PA1-16972, ThermoFisher Scientific), 1:2000 guinea-pig anti-C. burnetii primary antibody
[39] and 1:1000 rat anti-LAMP (Catalog # 553792, BD Biosciences) primary antibody in sapo-
nin-BSA-PBS for 1 hour. THP-1 cells were stained with 1:500 guinea-pig anti-human PLIN2
primary antibody (Catalog # 20R-AP002, Fitzgerald Industries International, Acton, MA),
1:2000 rabbit anti-C. burnetii primary antibody and 1:1000 rat anti-LAMP primary antibody
in saponin-BSA-PBS for 1 hour. After three washes with PBS, cells were stained with 1:2000
AlexaFluor 488 anti-rabbit, AlexaFluor 594 anti-guinea pig and AlexaFluor 647 anti-rat sec-
ondary antibodies (Invitrogen) for 1 hour. ProLong Gold mount (Invitrogen) was added to
the wells after washing with PBS and slides visualized on a Leica inverted DMI6000B micro-
scope (100X oil). Due to the lack of clear demarcation of LDs in z-stack images, LD numbers
per cell were manually counted on the microscope in each z-plane. LD numbers in 25 cells per
condition were counted in duplicate in each of three individual experiments, with only bacte-
ria-containing cells counted for C. burnetii-infected cells.
Inhibitors
Each LD homeostasis inhibitor used was diluted in DMSO based on manufacturer’s instruc-
tions and optimum inhibitor concentration was determined based on 100% host cell viability
determined by trypan blue staining, and changes in LD numbers per cell. The optimum con-
centrations determined for each inhibitor was: Triacsin C (Enzo Life Sciences, Farmingdale,
NY, USA)– 10 µM, T863 (Sigma-Aldrich)– 10 µM, CAY10499 (Cayman Chemicals, Ann
Arbor, MI, USA) - 10 µM, Atglistatin (Cayman Chemicals)– 20 µM.
C. burnetii growth by fluorescent infectious focus-forming unit (FFU) assay
To measure growth of C. burnetii in wild-type and acat-1-/- MH-S cells, 5x104 cells/well were
infected for 1 hour in a 48 well plate, washed with PBS, and then incubated with media con-
taining respective vehicle and inhibitors. At the indicated time points, the media was removed
and cells were incubated with sterile water for 5 min, pipetted up and down and the lysate
diluted 1:5 in 2% FBS-RPMI. Serial dilutions were added to 24 well plate containing confluent
monolayers of Vero cells, incubated for 5 days, fixed with methanol and stained with rabbit
anti-C. burnetii antibody as well as DAPI to confirm monolayer integrity. Four fields per well
were captured on an Evos automated microscope (ThermoFisher) with 4X objective and fluo-
rescent foci units were quantitated using ImageJ. Each independent experiment was per-
formed in duplicate.
Lipid droplets during Coxiella burnetii infection
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Atglistatin-treatment of C. burnetii axenic cultures
To test bacterial sensitivity to atglistatin, ACCM-2 was inoculated at approximately 1x105 bac-
teria/ml with C. burnetii NMII and grown for 3 days as previously described [37]. Bacteria
(500 µl) were then incubated with DMSO or atglistatin in 24 well plates under normal C. bur-
netii culture conditions. Media was replenished every 24 hours by centrifuging the supernatant
at 20000xg for 10 min, and bacterial pellet resuspended in new media containing inhibitor.
After 4 days, bacteria were diluted 1:10 in 2% FBS-RPMI and serial dilutions were added to
confluent Vero cell monolayers in a 96 well ibidi-treated µplate. At 5 days post-infection, the
plate was stained and fluorescent foci were determined as above. Each independent experi-
ment was performed in duplicate.
Statistical analysis
Statistical analyses were performed using two-tailed paired t-test, ordinary one-way ANOVA
or two-way ANOVA with Tukey’s or Bonferroni’s multiple comparisons test in Prism (Graph-
Pad Software, Inc., La Jolla, CA).
Results
LD-associated genes are upregulated in C. burnetii-infected alveolar
macrophages
To examine the role of LDs in C. burnetii pathogenesis, we first analyzed the expression of
lipid homeostasis-related genes in infected cells. As C. burnetii preferentially infects alveolar
macrophages during natural infection, we utilized a mouse alveolar macrophage cell line
(MH-S) previously established as a model for C. burnetii infection [40]. Compared to mock-
infected cells at day 1 post-infection, C. burnetii infection upregulated the expression of genes
acat-1, acat-2, fabp-4 and apoE by more than 1.2 fold (Fig 1). While ACATs (acyl coA transfer-
ases) catalyze the formation of sterol esters, FABP-4 (fatty acid binding protein-4) facilitates
fatty acid transport for storage in LDs and APOE is involved in cholesterol efflux [41]. Upregu-
lation of two other genes, the LD coat protein plin-2 and the cholesterol efflux protein abca-1,
was not statistically significant. At the protein level, both ACAT1 and PLIN2 showed a 1.5-fold
Fig 1. LD-associated genes are upregulated in C. burnetii-infected alveolar macrophages. MH-S macrophages were
infected with wild-type C. burnetii and RNA was collected at day 1 post-infection. Gene expression analysis was
performed using Applied Biosystems lipid-regulated TaqMan Array. Fold change was calculated compared to mock-
infected samples. Error bars show the mean of 6 independent experiments +/- SEM  = p<0.05,  = p<0.001
compared to respective mock-infected cells as determined by two-tailed paired t-test.
https://doi.org/10.1371/journal.pone.0192215.g001
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increase compared to mock-infected cells (S1 Fig). These data suggest that LD-associated
genes are upregulated during C. burnetii infection.
C. burnetii infection results in bacterial protein synthesis-dependent host
cell LD accumulation
Previously, at 36 and 72 hours post-infection two separate microarray analyses of C. burnetii-
infected THP-1 cells reported upregulation of the LD coat protein-encoding gene plin-2 [29,
30]. Mahapatra et al. also reported upregulation of fabp-4 [29]. Together with our gene expres-
sion analysis, this suggests LD formation may be altered during C. burnetii infection. To test
this possibility, we stained LDs for the coat protein PLIN2 and quantitated LD numbers per cell
in C. burnetii-infected cells by fluorescence microscopy. On an average, mock-infected had less
than 50 LDs per cell during a 4 day experiment, irrespective of the time point (Fig 2A). In
Fig 2. C. burnetii infection leads to host cell LD accumulation and is dependent on bacterial protein synthesis and the T4BSS. Macrophages
were infected with C. burnetii and at different times post-infection, cells were stained for PLIN2 (LDs; green), C. burnetii (red) and nucleus (blue).
LD number per cell were quantitated by fluorescence microscopy. A) LD numbers in wild-type C. burnetii and dotA mutant- infected MH-S
macrophages. B) LD numbers in MH-S macrophages either uninfected, untreated or infected with wild-type C. burnetii and treated with
chloramphenicol (3µg/ml). C) LD numbers in wild-type C. burnetii and dotA mutant- infected THP-1 macrophage-like cells. D) Images of LDs and
bacteria in MH-S cells at day 1 post-infection imaged at 100X. Scale bar = 10 µm. Error bars show the mean of 3 independent experiments +/- SEM
 = p<0.05,  = p<0.01,  = p<0.001 as determined by ordinary one-way ANOVA with Tukey post-hoc test.
https://doi.org/10.1371/journal.pone.0192215.g002
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contrast, we observed a significant increase in LDs in infected cells, with an average of more
than 90 LDs/cell at 1, 2 and 4 days after C. burnetii infection (Fig 2A, gray circles). Notably,
LD accumulation occurred as early as 1 day post-infection, when the PV has not expanded and
the bacteria are not in log growth (Fig 2D and 2E). To determine the role of C. burnetii in host
cell LD accumulation, we blocked bacterial protein synthesis with chloramphenicol [29] and
quantitated LD numbers at indicated times. Chloramphenicol-treated C. burnetii-infected cells
Fig 3. Blocking LD formation increases C. burnetii growth. Wild-type C. burnetii growth in infected MH-S cells treated with different
inhibitors was measured at 2 and 4 days post-infection by FFU assay. A-D) Representative images for wild-type MH-S macrophages
treated with inhibitors, fixed, stained for PLIN2 (LDs; green) and C. burnetii (red) and imaged day 4 post-treatment at 100X. Scale bar = 10
µm. E) Growth while inhibiting LD formation with triacsin C (10 µM) in wild-type MH-S macrophages. Error bars represent the mean of 4
independent experiments +/- SEM.  = p<0.01 compared to vehicle-treated cells as determined by two-way ANOVA with Bonferroni
post-hoc test. F) ACAT1 protein expression in wild-type and acat-1-/- macrophages. Cell lysates were immunoblotted and ACAT1 protein
levels were compared with GAPDH as loading control. G) C. burnetii growth in vehicle-treated wild-type and acat-1-/- MH-S macrophages
and (H) T863-treated acat-1-/- MH-S macrophages. Error bars represent the mean of at least 3 independent experiments +/- SEM.,  =
p<0.05,  = p<0.001 as determined by two-way ANOVA with Bonferroni post-hoc test.
https://doi.org/10.1371/journal.pone.0192215.g003
Lipid droplets during Coxiella burnetii infection
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contained 50 or less LDs per cell similar to mock-infected cells (Fig 2B and 2G). This result sug-
gests C. burnetii protein synthesis is required for LD accumulation.
Host cell LD accumulation is dependent on the C. burnetii type 4B
secretion system (T4BSS)
C. burnetii manipulates the host cell by secreting bacterial effector proteins through the T4BSS
into the host cytoplasm. To further decipher C. burnetii’s role in LD accumulation, we ana-
lyzed LD numbers at 1, 2, and 4 days after infection with a C. burnetii T4BSS dotA mutant
[36]. While the wild-type C. burnetii-infected cells had more than 90 LDs per cell (Fig 2A,
closed circles; Fig 2E), T4BSS-mutant infected cells contained an average of 50 LDs, similar to
mock-infected cells (Fig 2A, triangles; Fig 2F). This suggests the LD accumulation in C. burne-
tii-infected alveolar macrophages involves the C. burnetii T4BSS.
To confirm the T4BSS-dependent increase in LD accumulation, we analyzed LD numbers
in human macrophage-like cells (THP-1). When compared to mock- or T4BSS mutant-
infected cells, wild-type C. burnetii-infected THP-1 cells had increased LD numbers at 1 and 4
days post-infection (Fig 2C), similar to mouse alveolar macrophages. Interestingly, we did not
observe T4BSS-dependent LD accumulation at 2 days post-infection. Overall these results
demonstrate that C. burnetii induces LD accumulation in human and mouse macrophages
through a T4BSS-dependent process.
Blocking LD formation increases C. burnetii growth
Given our finding that C. burnetii appears to actively manipulate host LDs through the T4BSS,
we next assessed the importance of LDs during C. burnetii infection. We first blocked LD for-
mation using triacsin C, a long chain fatty acyl CoA synthetase inhibitor [42]. Compared to
vehicle control, triacsin C significantly reduced macrophage LDs, with<5 LDs per cell (Fig 3A
and 3B). We next treated macrophages with triacsin C during C. burnetii infection, and quanti-
tated bacterial growth using a fluorescent infectious focus-forming unit (FFU) assay. At vari-
ous times post-infection, we recovered bacteria from MH-S cells, replated bacteria onto a
monolayer of Vero cells, and incubated for 5 days. After staining for C. burnetii, we counted
the number of fluorescent foci, with 1 focus unit equivalent to 1 viable bacterium. We also
quantitated bacterial growth by an agarose-based colony forming unit (CFU) assay. Surpris-
ingly, compared to vehicle-treated cells, triacsin C treatment increased C. burnetii growth
5-fold at 4 days post-infection (Fig 3E and S3A, S3 B and S3F Fig).
To further confirm this finding, we used CRISPR/Cas-9 to knockout acat-1 (Fig 3F), a gene
functionally responsible for sterol esterification in macrophages [43] and upregulated in C.
burnetii-infected cells (Fig 1). While acat-1-/- LDs lack sterol esters, fluorescence microscopy
revealed similar number of LDs in wild-type and acat-1-/- cells with an average of less than 40
LDs per cell during a 4-day experiment (Fig 3A and 3C). Furthermore, similar to wild-type
MH-S cells, infection of acat-1-/- cells with wild-type C. burnetii showed increased LD numbers
compared to mock-infected and dotA mutant-infected cells (S2A Fig) with an average of more
than 75 LDs/cell at 1, 2 and 4 days after C. burnetii infection. This increase was also dependent
on C. burnetii protein synthesis (S2B Fig). Compared to wild-type cells, C. burnetii growth in
acat-1-/- cells increased 2-fold at 4 days post-infection (Fig 3G and S3A, S3C and S3G Fig),
indicating that blocking sterol esterification favors C. burnetii growth. To further deplete both
TAG- and sterol ester-containing LDs, we treated acat-1-/- cells with the DGAT-1 inhibitor
T863, which specifically blocks formation of TAGs [44]. T863 treatment significantly reduced
LDs in acat-1-/- macrophages, compared to untreated wild-type or acat-1-/- macrophages (Fig
3A, 3C and 3D). T863 treatment of wild-type cells also increased C. burnetii growth (S3F Fig).
Lipid droplets during Coxiella burnetii infection
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Furthermore, C. burnetii growth increased 2-fold in T863-treated acat-1-/- cells compared to
vehicle-treated acat-1-/- cells (Fig 3H and S3A, S3D and S3G Fig), demonstrating that blocking
both TAG- and sterol ester-containing LDs improves C. burnetii growth.
Inhibiting LD breakdown blocks C. burnetii growth
Because blocking LD formation appeared to benefit C. burnetii, we next examined C. burnetii
growth after inhibiting LD breakdown. When cells or tissues require fatty acids or cholesterol,
cytosolic lipases, including adipose triglyceride lipase (ATGL) [3] and hormone sensitive lipase
(HSL) [2, 4], hydrolyze TAGs and sterol esters stored in LDs. ATGL catalyzes the initial step of
lipolysis converting TAGs to DAGs whereas HSL hydrolyses DAGs to MAGs [45]. To block
LD breakdown, we first inhibited HSL with a selective inhibitor CAY10499 [46]. HSL inhibi-
tor-treated cells showed no significant difference in C. burnetii growth compared to vehicle-
treated cells (Fig 4A) suggesting conversion of DAGs to MAGs is not important for bacterial
intracellular growth.
To further study the importance of LD breakdown, we inhibited ATGL with the selective
and competitive inhibitor atglistatin, which binds the ATGL patatin-like phospholipase
domain [47]. To eliminate the possibility of ATGL inhibiting a C. burnetii phospholipase, we
first measured viability of axenic C. burnetii cultures in the presence or absence of atglistatin
(Fig 4B). Treatment for 4 days had no effect on axenic bacterial growth, indicating atglistatin
does not directly affect C. burnetii.
We next tested the effect of atglistatin on intracellular bacteria. After atglistatin treatment
of wild-type MH-S cells, we observed larger LDs, although the number did not significantly
increase (Fig 4C). Interestingly, C. burnetii intracellular growth in atglistatin-treated wild-type
MH-S cells decreased approximately 5-fold, with essentially no growth (Fig 4D and S3A, S3E
and S3H Fig). Further, atglistatin-treated acat-1-/- cells, which contain TAG-rich LDs, also
showed reduced bacterial growth (Fig 4E) suggesting TAG hydrolysis to DAG is critical to sup-
port C. burnetii growth. Together, these data demonstrate that blocking LD breakdown, partic-
ularly TAG to DAG conversion significantly inhibits intracellular C. burnetii growth.
Discussion
Several intracellular pathogens intercept host cell LDs to promote their growth. While certain
viruses utilize LDs as platforms for assembly, many bacteria and parasites facilitate intracellu-
lar growth by exploiting LDs for nutrition. To understand the role of LDs during C. burnetii
infection, we assessed changes in LD numbers in C. burnetii-infected cells and determined the
effect of manipulating LD homeostasis on bacterial growth. Our studies revealed a bacterial
T4BSS-dependent increase in LD numbers in C. burnetii-infected macrophages. Further,
manipulating LD homeostasis significantly altered C. burnetii growth. While blocking LD for-
mation promoted C. burnetii growth, inhibiting LD breakdown, particularly hydrolysis of
TAGs to DAGs, dramatically decreased bacterial growth. Collectively, our data strongly sug-
gest LDs play an important role during C. burnetii intracellular growth.
LD formation requires sterol and fatty acid esterification by the enzymes ACAT and
DGAT, while LD lipolysis is catalyzed by HSL and ATGL. Once formed, LD maintenance
requires the LD-associated proteins PLINs. Previously, two separate microarray analyses
reported upregulation of plin-2 in C. burnetii-infected human macrophage-like cells (THP-1)
[29, 30], suggesting C. burnetii induced changes in host cell LDs. Although we did not observe
changes in plin-2 transcript levels, PLIN2 proteins levels did increase, and post-translational
regulation of plin-2 [48] could potentially contribute to changes in LD numbers in infected
macrophages. Consistent with upregulation of LD-formation genes acat and fabp-4, our results
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demonstrated that LD numbers increase in C. burnetii-infected mouse and human
macrophages.
Notably, LD accumulation occurred as early as day 1 post-infection, when the PV has not
expanded and the bacteria are not in log growth. This suggests that LD accumulation is not a
host response to a large and growing PV but could be in response to bacterial ligands or due to
a process actively manipulated by C. burnetii itself. Previously, based on microarray analysis of
C. burnetii-infected cells where bacterial protein synthesis was blocked, Mahapatra et al. iden-
tified 36 host cell genes specifically regulated by C. burnetii proteins during early stages of
infection. These genes were predominantly involved in the innate immune response, cell death
and proliferation, vesicular trafficking, cytoskeletal organization and lipid homeostasis. Inter-
estingly, changes in plin-2 expression level in infected cells was dependent on C. burnetii
Fig 4. Inhibiting LD breakdown blocks C. burnetii growth. Effect of HSL inhibitor CAY10499 and ATGL inhibitor
atglistatin on viability of axenic and intracellular wild-type C. burnetii was determined by FFU assay. A) C. burnetii
growth in CAY10499-treated (10 µM) and vehicle-treated wild-type MH-S macrophages. Error bars represent the
mean of 3 independent experiments +/- SEM. ns = not significant compared to vehicle-treated cells as determined by
two-way ANOVA with Bonferroni post-hoc test. B) Direct effect of atglistatin on wild-type C. burnetii. Atglistatin was
added to axenic C. burnetii cultures and bacterial viability was determined at day 4 using FFU assay. Error bars
represent the mean of 3 independent experiments +/- SEM. ns = not significant compared to vehicle treatment as
determined by ordinary one -way ANOVA with Tukey post-hoc test. C) Representative image for wild-type MH-S
macrophages treated with atglistatin, fixed, stained for PLIN2 (LDs; green) and C. burnetii (red) and imaged day 4
post-treatment at 100X. Scale bar = 10 µm. D) C. burnetii growth in atglistatin-treated (20 µM) and vehicle-treated
wild-type MH-S macrophages. Error bars represent the mean of 4 independent experiments +/- SEM.  = p<0.05,
 = p<0.0001 compared to vehicle-treated cells as determined by two-way ANOVA with Bonferroni post-hoc test.
E) C. burnetii growth in atglistatin-treated (20 µM) and vehicle-treated acat-1-/- MH-S macrophages. Error bars
represent the mean of 4 independent experiments +/- SEM.  = p<0.01 compared to vehicle-treated cells as
determined by two-way ANOVA with Bonferroni post-hoc test.
https://doi.org/10.1371/journal.pone.0192215.g004
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protein synthesis [29] suggesting a role for bacterial proteins in LD accumulation. In agree-
ment with this data, we found that blocking C. burnetii protein synthesis prevented increased
LD accumulation in mouse alveolar macrophages at all analyzed times post-infection. These
data together suggest that C. burnetii actively manipulates host LDs at early stages of infection.
Beginning 1 hour post-infection in bone marrow-derived macrophages and 8 hours in
HeLa cells, C. burnetii secretes effector proteins via T4BSS [49] to modulate host cell functions
and promote its intracellular survival. Intriguingly, a C. burnetii T4BSS mutant did not
increase host cell LD numbers, suggesting a T4BSS-dependent increase in LD accumulation
during wild-type C. burnetii infection. The same result was observed in both mouse and
human macrophages, demonstrating that the C. burnetii-induced increase in LDs is indepen-
dent of species and dependent on the C. burnetii T4BSS. This finding suggests that one or
more T4BSS effector proteins may actively manipulate LDs, possibly by directly targeting pro-
teins involved in LD homeostasis. For example, the Salmonella Typhimurium type 3 secretion
system (T3SS) effector protein SseJ esterifies cholesterol and increases LD numbers when
ectopically expressed in epithelial and macrophage cells [20]. The C. trachomatis secreted pro-
tein Lda3 localizes to the LD surface and is involved in LD translocation into the Chlamydia-
containing inclusion [22]. Thus far, none of the identified C. burnetii T4BSS secreted effector
proteins localize to host LDs or associate with proteins involved in LD homeostasis. It is also
possible that rather than de novo formation, increased LD numbers result from fission of pre-
existing LDs [50]. As observed by microscopy, the LD size in C. burnetii-infected macrophages
appeared smaller than the mock- or T4BSS mutant-infected macrophages. Smaller, more
numerous LDs might result from C. burnetii T4BSS-mediated fission of the existing LDs.
While C. burnetii T4BSS effector proteins might directly target LD homeostasis pathways,
LD accumulation may also be a host innate immune response. In other diseases, LD accumula-
tion occurs during the inflammatory response in macrophages in atherosclerotic lesions [51],
leukocytes from joints of patients with inflammatory arthritis [52], and eosinophils in allergic
inflammation [53]. Thus, an innate immune response to the T4BSS apparatus or T4BSS effec-
tor proteins may increase LD numbers in C. burnetii-infected macrophages. Additionally,
bystander response to bacterial components including TLR ligand LPS could result in
increased LD accumulation [16, 54]. However, T4BSS mutant and protein-synthesis blocked
C. burnetii have similar surface ligands to wild-type bacterium but show no increase in LD
accumulation thus arguing against the contribution of C. burnetii LPS and other surface
ligands. Overall, while our data demonstrate that the C. burnetii T4BSS is involved in LD accu-
mulation in both mouse and human macrophages, the bacterial effector proteins and the spe-
cific LD processes targeted remain unknown.
Besides T4BSS-dependent increase in LD accumulation, we found that manipulating LD
homeostasis, in particular fatty acids, significantly altered C. burnetii growth. Surprisingly,
blocking LD formation by pharmaceutical and genetic approaches, which increases the avail-
ability of free fatty acids, led to improved C. burnetii fitness in macrophages. Conversely,
reducing fatty acid availability by inhibiting breakdown of LD-derived TAGs to DAGs blocked
C. burnetii growth. Intriguingly, DAG to MAG conversion did not affect bacterial growth, sug-
gesting that DAGs in particular are critical for C. burnetii infection. DAGs and other fatty
acids liberated during LD breakdown can be re-esterified or serve as signaling cofactors, build-
ing blocks for membranes, or substrates for β-oxidation [2]. Other bacterial pathogens are
known to target LDs as a source of lipids. For example, M. tuberculosis uses free fatty acids as a
source of energy and carbon [15, 55], while C. trachomatis is hypothesized to break down bac-
terial inclusion-associated host LDs to provide lipids for bacterial growth [14]. It not known if
free fatty acids or sterols liberated from LDs, either in the cytosol or possibly in PV lumen, are
used directly by C. burnetii.
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In addition to serving as a source of free fatty acids and sterols, macrophage LDs are rich in
substrates and enzymes that generate prostaglandins and leukotrienes, which are arachidonic
acid-derived inflammatory lipid mediators [56, 57]. In M. leprae-infected Schwann cells and
M. bovis BCG-infected macrophages, increased LD biogenesis correlates with increased pro-
duction of prostaglandin E2 (PGE2), linking LDs to the production of innate immune modula-
tors [17, 58]. PGE2 has a potential role in inhibiting TH1 responses important in clearance of
intracellular pathogens [24] including C. burnetii [59]. Interestingly, elevated levels of PGE2
were observed in C. burnetii endocarditis patients and linked to C. burnetii-mediated immuno-
suppression. Koster et al. reported lymphocytes from chronic Q fever patients being unrespon-
sive to C. burnetii antigens, an effect reversed by PGE2 suppression with indomethacin [60]. In
addition, after stimulation with C. burnetii antigens, monocytes from Q fever patients pro-
duced PGE2, which in turn downregulated T lymphocyte-mediated IL-2 and IFNγ produc-
tion. Interestingly, PGE2 synthesis inhibitor Piroxicam reversed this downregulation of pro-
inflammatory cytokine production [61]. Thus, while PGE2 appears to play a role in Q fever
patients, the relationship between C. burnetii-induced LDs and PGE2 production is not
known. Considering that LD breakdown can serve multiple functions, C. burnetii could use
LDs either as a source of nutrients or for production of lipid immune mediators like PGE2,
which could then modulate the host cell response to promote C. burnetii intracellular growth.
In summary, our data demonstrate that LD homeostasis is important for C. burnetii intra-
cellular survival. Because the C. burnetii T4BSS is involved in LD accumulation, characterizing
bacterial T4BSS effector proteins that target host LD homeostasis will help further understand
the role of LDs in C. burnetii pathogenesis.
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S1 Fig. LD-associated protein levels in C. burnetii-infected alveolar macrophages. MH-S
macrophages were infected with wild-type C. burnetii and cell lysates collected at day 2 post-
infection were immunoblotted for (A) PLIN2 and (B) ACAT1. Shown is a representative blot
from three separate experiments. (C) Protein levels were quantitated, normalized to GAPDH,
and the fold change over mock-infected cells plotted. Error bars show the mean of 3 indepen-
dent experiments +/- SEM  = p< .05,  = p<0.01 compared to respective mock-infected as
determined by unpaired t-test.
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S2 Fig. C. burnetii infection leads to host cell LD accumulation in acat-1-/- MH-S cells and
is dependent on bacterial protein synthesis and the T4BSS. acat-1-/- macrophages were
infected with C. burnetii and at different times post-infection, cells were stained for PLIN2, C.
burnetii and nucleus. LD number per cell were quantitated by fluorescence microscopy. A) LD
numbers in wild-type C. burnetii and dotA mutant- infected acat-1-/- macrophages. B) LD
numbers in acat-1-/- macrophages infected with wild-type C. burnetii and treated with chlor-
amphenicol (3ug/ml). Error bars show the mean of 3 independent experiments +/- SEM 
= p<0.0001 as determined by ordinary one-way ANOVA with Tukey post-hoc test.
(TIFF)
S3 Fig. Altering LD formation and breakdown affects C. burnetii intracellular growth.
Wild-type C. burnetii growth in infected MH-S cells treated with different inhibitors was mea-
sured at day 4 post-infection by CFU assay. A-E) Representative images for wild-type MH-S
macrophages treated with inhibitors, fixed, stained for PLIN2 (LDs; green) and C. burnetii
(red) and imaged day 4 post-treatment at 20X oil. Scale bar = 20 µm. F) Growth while inhibit-
ing LD formation with triacsin C (10 µM) and T863 (10 µM) in wild-type MH-S macrophages.
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Error bars represent the mean of 3 independent experiments +/- SEM.  = p<0.05,  = p
<0.01 compared to vehicle-treated cells as determined by two-way ANOVA with Bonferroni
post-hoc test. G) Growth in wild-type and acat-1-/- macrophages treated with or with T863 (10
µM). Error bars represent the mean of 3 independent experiments +/- SEM.  = p<0.01, 
= p<0.001 as determined by two-way ANOVA with Bonferroni post-hoc test. H) Growth in
vehicle and atglistatin-treated wild-type MH-S macrophages. Error bars represent the mean of
3 independent experiments +/- SEM.,  = p<0.001 as determined by two-tailed paired t-test.
(TIFF)
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